Skip to content

Site Map | Privacy Policy

Legal Disclaimer


Please consult with your healthcare professional to see if ZEGERID is right for you. The content of this Web site is not a substitute for professional medical advice and should not be interpreted as treatment recommendations or relied on for medical diagnosis or treatment. Only a physician who has had an opportunity to interact with a patient in person, with access to a patient's records and the opportunity to conduct appropriate follow-up, can diagnose a patient's condition and provide recommendations for treatment.

The information provided on this Web site is presented in summary form, is general in nature, and is provided for informational purposes only. The information on this site is intended only for the purpose of helping patients and family members better understand certain health conditions and treatment options. Due to the rapid changes in medical science, the information provided on this Web site may not be current.

Never disregard medical advice or delay in seeking it because of something you have read on this Web site.

This site is intended for the exclusive use of residents of the United States of America.


Vermont Price Disclosure


Your Heartburn | Acid Reflux Symptoms | Acid Reflux Disease | Why Choose ZEGERID? |
For ZEGERID Patients | Seeing Your Doctor | Important Safety Information

Product Description
ZEGERID contains omeprazole, a proton pump inhibitor (PPI), and sodium bicarbonate, an antacid.

Important Safety Information about ZEGERID
ZEGERID is indicated for the treatment of heartburn and other symptoms of acid reflux disease. ZEGERID is used to treat and maintain the healing of erosive esophagitis, which may result from acid reflux. ZEGERID is also indicated for the short-term treatment of active duodenal ulcer and of active benign gastric ulcer.

Side effects of ZEGERID include headache, diarrhea and abdominal pain. Relief of your symptoms while on ZEGERID does not rule out that other serious stomach conditions may exist.

ZEGERID Capsules contain 303 mg of sodium per dose. ZEGERID Powder for Oral Suspension contains 460 mg of sodium per dose. The sodium is in the form of sodium bicarbonate and these amounts should be taken into consideration by anyone on a sodium-restricted diet. People with metabolic alkalosis and hypocalcemia should not take sodium bicarbonate.

ZEGERID Capsules and ZEGERID Powder for Oral Suspension have the same amount of sodium bicarbonate in both the 20mg and 40mg dosages. Two 20mg doses are not equivalent to one 40mg dose, and two 20mg doses should not be used in place of one 40mg dose.

ZEGERID should not be taken by anyone with a known hypersensitivity to any component of the formulation.

To learn more about ZEGERID, see full prescribing information and talk with your doctor.

Please consult with your healthcare professional to see if ZEGERID is right for you. The content of this Web site is not a substitute for professional medical advice and should not be interpreted as treatment recommendations or relied on for medical diagnosis or treatment. Please see complete Legal Disclaimer.

Nexium is a trademark of AstraZeneca LP; Prevacid is a trademark of Tap Pharmaceutical Products, Inc.; Protonix is a trademark of Wyeth Pharmaceuticals Inc.; Prilosec is a trademark of Astra Merck Inc.; Aciphex is a trademark of Eisai Co., Ltd.